Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Can
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CADL) | Delayed: 8.10 -0.28 (3.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.38 | 52 Week High | $ | |||
| Open | $8.33 | 52 Week Low | $ | |||
| Day High | $8.33 | P/E | N/A | |||
| Day Low | $8.07 | EPS | $ | |||
| Volume | 120,036 | |||||
